Renovocell Biologics Profile
Key Indicators
- Authorised Capital ₹ 10.00 K
- Paid Up Capital ₹ 10.00 K
- Company Age 1 Year 1 Month
About Renovocell Biologics
Renovocell Biologics Private Limited (RBPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 January 2024 (One year and one month 11 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 10.00 K and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Devaiah Pagidipati, Satyanarayana Guttula, Siva Darsi, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U21001TS2024PTC180955
- Company No.
180955
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Renovocell Biologics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyanarayana Guttula  | Additional Director | 27-Sep-2024 | Current |
| Devaiah Pagidipati | Additional Director | 27-Sep-2024 | Current |
| Siva Darsi | Director | 11-Jan-2024 | Current |
| Ravi Vendra | Director | 11-Jan-2024 | Current |
Financial Performance of Renovocell Biologics.
Enhance accessibility to Renovocell Biologics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Renovocell Biologics?
Unlock access to Renovocell Biologics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
E Vaidya Private LimitedDevaiah Pagidipati is a mutual person
Inventcorp Technologies LimitedDevaiah Pagidipati is a mutual person
Bheem Online Services LimitedDevaiah Pagidipati is a mutual person
United Health Systems Private LimitedDevaiah Pagidipati is a mutual person
Awlencan Innovations India LimitedDevaiah Pagidipati is a mutual person
Southern Online Bio Technologies LimitedDevaiah Pagidipati is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Renovocell Biologics?
Unlock and access historical data on people associated with Renovocell Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Renovocell Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renovocell Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.